FDA record · 503B outsourcing facility

ProRx LLC: FDA 503B outsourcing facility record

ProRx LLC in Exton, PA is on FDA's register of 503B outsourcing facilities. Registered since Apr 27, 2022; last FDA inspection Sep 19, 2025; Form 483 issued at that inspection: Yes; action FDA lists: Warning Letter Issued 4/7/2026. Register updated by FDA Sep 30, 2026.

Julian CaraulaniFounder, PriceTracker GLP-1FDA register read Oct 3

Status: Registered since Apr 27, 2022; last FDA inspection Sep 19, 2025.

What FDA’s register states

FDA register entry for ProRx LLC
Field	What FDA’s record states	Source
Facility	ProRx LLC	FDA register
Location	Exton, PA	FDA register
First registered	Apr 27, 2022	FDA register
Most recent registration	Feb 20, 2026	FDA register
Last FDA inspection	Sep 19, 2025	FDA register
Form 483 issued	Yes	FDA register
Recall conducted	No	FDA register
Action based on last inspection	Warning Letter Issued 4/7/2026	FDA register
Earlier compounding action	Not published by FDA	n/a
Intends to compound sterile drugs from bulk	Yes	FDA register

Registration is a filing, not an approval.A Form FDA 483 lists what investigators observed; in FDA’s words it “does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.” “Open” means FDA has not determined whether further action will be taken.

GLP-1 warning letters to a firm of this name

Matched by name; FDA’s letter gives the address it was sent to.

Source

Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Sep 30, 2026, read Oct 3, 2026. The table does not include State Board of Pharmacy actions. All 98 registered facilities